Search results for
Pharmaceuticals
-
May 27, 2026
How rupee depreciation might help these 3 Indian sectors gain revenue
A falling rupee may soften the impact of the West Asian conflict for sectors that earn heavily in foreign currency
-
May 05, 2026
Cannabis high: A goldmine waiting to be tapped in India?
From stigma to science, is India about to witness a cannabis comeback?
-
March 11, 2026
Will your medicines get costlier because of Iran war? Indian Pharma exports could see Rs 5000 crore in losses
Rising raw material costs and freight charges due to the war in Iran are now poised to increase medicine prices in India, impacting both local manufacturing and exports to the Middle East and North Africa
-
December 19, 2025
Tata Chemicals unit to buy Singapore-based Novabay for €25 million
Novabay makes premium‑grade sodium bicarbonate used in pharma, food, personal care products
-
October 06, 2025
What does Eli Lilly do? Mounjaro maker to invest $1 billion in India
American drugmaker is set to begin recruitment for its Hyderabad location
-
October 03, 2025
Rubicon IPO could be the pharma hit that India needs
Ahead of IPO, Rubicon Research presents solid fundamentals in a competitive pharmaceutical market marred by Trump tariffs
-
September 26, 2025
The hidden costs of Donald Trump’s 100% pharma tariff
Expect drug and health-care stakeholders to feel the shock first, and any reshoring benefits—if they materialise—to lag well behind
-
September 26, 2025
Be afraid, be very afraid: As Trump walks the (threat) talk, India should be worried
What India perhaps had not calculated in the midst of it all were two developments. One, the swift moves by other nations in the face of Trump’s tariff threats, and two, Trump’s own domestic compulsions
-
September 26, 2025
Pharma Paradox: When strong business doesn't mean strong stocks
Despite impressive earnings and strong exports, the recent Trump tariffs on India's pharmaceutical sector pushed major sectoral stocks down, including Sun Pharma, Cipla, and Dr Reddy's
-
September 26, 2025
Sun Pharma biggest loser in Sensex, shares tank 3%
The 30-pack Sensex fell 450 points with Sun Pharma leading the dip; Medical stocks get punished after Trump’s 100 per cent tariff announcement
-
September 26, 2025
Trump imposes 100% pharma tariffs: Why India is directly in the firing line
Trump drug tariffs announced 100% duties on branded drugs by October 1st, impacting global pharmaceutical manufacturers, especially India, the leading exporter of generics to the US
-
September 22, 2025
Who is Achin Gupta? Cipla to get new Global CEO as Umang Vohra will step down
Achin Gupta joined Cipla in 2021 as CEO - One India Business (SMP), the company's segment focused on the Indian market
-
July 14, 2025
Sun Pharma, Incyte settle lawsuit over alopecia drug LEQSELVI
In a joint statement, the companies announced that both parties will withdraw the ongoing lawsuit and release each other from all legal claims related to the matter
-
June 30, 2025
Torrent Pharma looks to expand India business, contract development with JB Pharma deal
Gujarat-based pharma giant announces acquisition of rival JB Chemicals and Pharmaceuticals stake for ₹11,917 crore in first phase
-
May 21, 2025
WHO raises $170 million at high-level investment round: Here is how much each member pledged
Weight-loss drug manufacturer among top contributors to the World Health Organization
-
May 16, 2025
Top goods exported from India: Engineering products, drugs, coffee, and more
India exported more than $437 billion in merchandise goods in fiscal 2024-2025, latest govt data showed
-
April 10, 2025
UP State Industrial Development Authority, IIT BHU sign MOU to set up pharma park in Bundelkhand
Bundelkhand is one of the least developed regions in the country. The park will com eup in 1,472 acres of land
-
April 04, 2025
India's pharma sector treads cautiously as Trump tariff threat continue to loom large
Nifty Pharma took a beating on Friday declining over four per cent, after Donald Trump hinted at a separate tariff for pharmaceutical imports
-
January 15, 2025
Japanese Biopharmaceutical major Takeda sets up its first Global Innovation Capability Center in Asia in Bengaluru
The Bengaluru centre will also be Takeda's largest centre when compared to the other two centrers in Slovakia and Mexico
-
December 28, 2024
Here are the two medicines declared as ‘spurious drugs’ by Indian pharma watchdog CDSCO
Ongoing regulatory surveillance finds drug samples did not meet quality criteria as the Central Drug Standards Control Organisation cracks down on spurious medicines
-
December 24, 2024
E-pharmacies to witness steady revenue growth
Operating losses for e-pharmacies will come down
-
November 28, 2024
Cipla calls Rs 53 lakh GST fine ‘arbitrary and unjustified’, plans to appeal
The Central Goods & Service Tax and Central Excise office in Lucknow slaps penalty on pharma giant Cipla for alleged GST credit filing
-
November 14, 2024
Mexican drug regulator slaps Rs 27 lakh fine on Indian pharma giant Dr Reddy's, shares down
Mexico's Comisi Federal para la Protecci Contra Riesgos Sanitarios (COFEPRIS) imposed a penalty of MXN 6.51 lakh on Dr Reddy's Laboratories
-
June 27, 2024
Nicotinell buy to give big boost to Dr Reddy's consumer healthcare play
Nicotinell acquisition gives a boost to Dr Reddy’s over-the-counter sales
-
May 07, 2024
India exported half its pharma produce last year
Efforts are on to replicate the pharma success in medical device industry as well
Results 1-25 of 89 for Pharmaceuticals
